MedTech partnerships in France - Caredis

Who trusts us

Selected MedTech Companies Supported in France

Caredis supports international MedTech companies in accessing and developing the French market. Our experience covers reimbursement and early market development through to go-to-market execution and commercial scale-up, across a range of therapeutic areas and innovative medical technologies.

Cardiology and structural heart

Cardiology & Structural Heart

Supporting innovative solutions across interventional cardiology, structural heart and related technologies.

Canada

Neovasc

Structural Heart – Refractory Angina

India

Translumina

Interventional Cardiology – Coronary Stents

USA

Cardiac Dimensions

Structural heart– Heart Failure – Mitral Regurgitation

Canada

Elixir Medical

Interventional Cardiology – Coronary Technologies

Canada

Shockwave Medical

Interventional Cardiology – Intravascular Lithotripsy

Canada

Zoll

Interventional Cardiology – Acute Myocardial Infarction

Gastroenterology

Gastroenterology

Contributing to the development of innovative therapies in gastrointestinal health.

New Zealand

The Insides Company

Gastroenterology – Intestinal Failure – Chyme Reinfusion

switzerland

Implantica

Gastroenterology – Gastroesophageal Reflux Disease

MedTech specialties

Other MedTech Specialties

Supporting innovative solutions in a range of therapeutic and surgical areas.

china

SiBionics

Diabetes – Continuous Glucose Monitoring

France

BCV

Neuroradiology – Endovascular Access

Germany

DynaMesh

Gastroenterology – Gastroesophageal Reflux Disease

Germany

Sennewald Medizintechnik

Oncology – Regional Hyperthermia

See how we  can help you 

Let’s discuss your market access and commercial development needs in France.